Verifying…
Home / Drug A–Z / Krishat Bisacodyl Tablet

Krishat Bisacodyl Tablet

NAFDAC Reg. No. A11-1117 · Drug

Registered with NAFDAC — registration activeAs of 5 November 2026 · synced automatically from official sources.
Product
Krishat Bisacodyl Tablet
NAFDAC number
A11-1117
Active ingredient
Bisacodyl
Strength
5 mg
Form
Tablet
Pack size
10 x 10's (in PVC-Alu blisters)
Manufacturer
Not listed
Applicant (holder)
Krishat Pharma Industries Limited
Approved
10 Nov 2020
Status
Inactive View on NAFDAC ↗
Registration valid to
9 Nov 2025
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Krishat Bisacodyl Tablet is on the NAFDAC register with an active registration (A11-1117). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Krishat Bisacodyl Tablet is used for

From the official U.S. FDA label for bisacodyl, the active ingredient registered with NAFDAC.

What it is used for

for relief of occasional constipation and irregularity this product generally produces bowel movement in 15 minutes to 1 hour

Purpose

Stimulant laxative

Possible side effects

you have rectal bleeding or fail to have a bowel movement after using this product. These could be signs of a serious condition. you need to use a laxative for more than 1 week

Warnings

For rectal use only Ask a doctor before use if you have stomach pain, nausea or vomiting noticed a sudden change in bowel habits that lasts more than 2 weeks When using this product it may cause stomach discomfort, faintness, rectal burning and mild cramps Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after using this product. These could be signs of a serious condition. you need to use a laxative for more than 1 week If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Pregnancy & breastfeeding

If pregnant or breast-feeding, ask a health professional before use.

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Krishat Bisacodyl Tablet

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Krishat Bisacodyl Tablet

What is in Krishat Bisacodyl Tablet?

Krishat Bisacodyl Tablet contains Bisacodyl (5 mg), as tablet, according to its NAFDAC registration record.

Is Krishat Bisacodyl Tablet registered with NAFDAC?

Yes. Krishat Bisacodyl Tablet is listed on the NAFDAC register under registration number A11-1117, and its registration is active as of 5 November 2026.

Has Krishat Bisacodyl Tablet been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Krishat Bisacodyl Tablet in our automatically synced alert list.

How can I check that my pack of Krishat Bisacodyl Tablet is genuine?

Run a free authenticity scan with the NAFDAC number A11-1117, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Krishat Bisacodyl Tablet used for?

for relief of occasional constipation and irregularity this product generally produces bowel movement in 15 minutes to 1 hour (Summarised from the official U.S. FDA label for bisacodyl. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Krishat Bisacodyl Tablet? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.